Literature DB >> 24926956

Increased visceral adiposity and cortisol to cortisone ratio in adults with congenital lifetime isolated GH deficiency.

Elenilde Gomes-Santos1, Roberto Salvatori, Thiago O Ferrão, Carla R P Oliveira, Rachel D C A Diniz, João A M Santana, Francisco A Pereira, Rita A A Barbosa, Anita H O Souza, Enaldo V Melo, Carlos C Epitácio-Pereira, Alécia A Oliveira-Santos, Ingrid A S Oliveira, Julianne A Machado, Francisco J Santana-Júnior, José A S Barreto-Filho, Manuel H Aguiar-Oliveira.   

Abstract

CONTEXT: Adult-onset GH deficiency (GHD) increases visceral adiposity and the activity of the enzyme 11β-hydroxysteroid dehydrogenase, which converts cortisone (E) to cortisol (F), both linked to insulin resistance and increased cardiovascular risk. Conversely, we reported that adults with congenital isolated GHD (IGHD) have increased insulin sensitivity.
OBJECTIVE: To assess the type of fat distribution and the amount of visceral and sc fat and to correlate them to the F/E ratio in adults with untreated IGHD due to a mutation in the GHRH receptor gene.
METHODS: Body composition was assessed by dual-energy x-ray absorptiometry, thickness of sc and visceral fat was measured by sonography, and serum F and E were measured in 23 IGHD subjects and 21 age-matched controls.
RESULTS: Waist/hip ratio (WHR), trunk fat, and trunk/extremity fat (TR/EXT) ratio were higher in IGHD subjects. Visceral fat index (VFI) (but not sc fat index [SFI]) was higher in IGHD. F and F/E ratio were also higher in IGHD. In all 44 individuals, WHR correlated with TR/EXT ratio, thickness of visceral fat, VFI/SFI ratio, F, and F/E ratio. TR/EXT ratio correlated with visceral fat thickness, VFI/SFI ratio, and F. Age had a significant effect on VFI and on F/E ratio. Body mass index SD score and WHR have a similar significant effect on TR/EXT ratio and on F/E ratio.
CONCLUSIONS: Lifetime congenital untreated IGHD causes increased visceral adiposity with a high F/E ratio. However, the increased insulin sensitivity suggests that visceral adiposity needs a minimal GH secretion to translate into increased insulin resistance.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24926956     DOI: 10.1210/jc.2014-2132

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  15 in total

Review 1.  Growth Hormone Deficiency: Health and Longevity.

Authors:  Manuel H Aguiar-Oliveira; Andrzej Bartke
Journal:  Endocr Rev       Date:  2019-04-01       Impact factor: 19.871

2.  Growth hormone deficiency in patients with obesity.

Authors:  Roberto Salvatori
Journal:  Endocrine       Date:  2015-03-10       Impact factor: 3.633

3.  Subjects with isolated GH deficiency due to a null GHRHR mutation eat proportionally more, but healthier than controls.

Authors:  Alécia A Oliveira-Santos; Roberto Salvatori; Elenilde Gomes-Santos; João A M Santana; Ângela C G B Leal; Rita A A Barbosa; Carla R P Oliveira; Anita H O Souza; Eugênia H O Valença; Manuel H Aguiar-Oliveira
Journal:  Endocrine       Date:  2015-06-23       Impact factor: 3.633

4.  Developments in our understanding of the effects of growth hormone on white adipose tissue from mice: implications to the clinic.

Authors:  Darlene E Berryman; Brooke Henry; Rikke Hjortebjerg; Edward O List; John J Kopchick
Journal:  Expert Rev Endocrinol Metab       Date:  2016-02-24

5.  The visceral adiposity index is associated with insulin sensitivity and IGF-I levels in adults with growth hormone deficiency.

Authors:  Alessandro Ciresi; Stefano Radellini; Valentina Guarnotta; Carla Giordano
Journal:  Endocrine       Date:  2016-08-13       Impact factor: 3.633

6.  Vasculometabolic effects in patients with congenital growth hormone deficiency with and without GH replacement therapy during adulthood.

Authors:  Isabela Peixoto Biscotto; Valéria Aparecida Costa Hong; Rafael Loch Batista; Berenice Bilharinho Mendonca; Ivo Jorge Prado Arnhold; Luiz Aparecido Bortolotto; Luciani Renata Silveira Carvalho
Journal:  Pituitary       Date:  2020-10-24       Impact factor: 4.107

7.  Cerebral vasoreactivity, a surrogate marker of cerebrovascular disease, is not impaired in subjects with lifetime, untreated, congenital isolated GH deficiency.

Authors:  Cindi G Marinho; Hyder A Melo; Roberto Salvatori; Marco A P Nunes; Carla R P Oliveira; Viviane C Campos; Cynthia S Barros-Oliveira; Alécia A Oliveira-Santos; Nelmo V Menezes; Hertz T Santos-Júnior; Elenilde G Santos; Manuela A Melo; Joselina L M Oliveira; Enaldo V Melo; Manuel H Aguiar-Oliveira
Journal:  Endocrine       Date:  2020-07-12       Impact factor: 3.633

8.  Liver status in congenital, untreated, isolated GH deficiency.

Authors:  Rachel D C A Diniz; Renata M Souza; Roberto Salvatori; Alex Franca; Elenilde Gomes-Santos; Thiago O Ferrão; Carla R P Oliveira; João A M Santana; Francisco A Pereira; Rita A A Barbosa; Anita H O Souza; Rossana M C Pereira; Alécia A Oliveira-Santos; Allysson M P Silva; Francisco J Santana-Júnior; Eugênia H O Valença; Viviane C Campos; Manuel H Aguiar-Oliveira
Journal:  Endocr Connect       Date:  2014-08-12       Impact factor: 3.335

Review 9.  Disruption of the GHRH receptor and its impact on children and adults: The Itabaianinha syndrome.

Authors:  Manuel H Aguiar-Oliveira; Roberto Salvatori
Journal:  Rev Endocr Metab Disord       Date:  2020-09-16       Impact factor: 6.514

10.  Circulating microRNA profile in humans and mice with congenital GH deficiency.

Authors:  Tatiana D Saccon; Augusto Schneider; Cindi G Marinho; Allancer D C Nunes; Sarah Noureddine; Joseph Dhahbi; Yury O Nunez Lopez; Gage LeMunyan; Roberto Salvatori; Carla R P Oliveira; Alécia A Oliveira-Santos; Nicolas Musi; Andrzej Bartke; Manuel H Aguiar-Oliveira; Michal M Masternak
Journal:  Aging Cell       Date:  2021-06-12       Impact factor: 9.304

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.